# Evaluation of adding autologous platelet-rich plasma to embryo transfer media on implantation outcomes: An RCT

**Authors:** Marzie Sanuie Farimani, Ashraf Aleyasin, Ashraf Moini, Iraj Amiri, Jalal Poorolajal, Fahime Salari Shahrbabaki

PMC · DOI: 10.18502/ijrm.v23i4.18785 · International Journal of Reproductive Biomedicine · 2025-06-10

## TL;DR

This study found that adding platelet-rich plasma to embryo transfer media does not directly improve implantation outcomes in infertile women.

## Contribution

The study provides new evidence that PRP may not directly enhance embryo implantation during transfer.

## Key findings

- PRP addition to embryo transfer media did not significantly improve chemical pregnancy rates.
- No significant difference in gestational sac or fetal heart activity between the PRP and control groups.
- Positive effects of PRP in prior studies may be due to indirect improvements in the uterine environment.

## Abstract

Several recent studies have shown the beneficial effect of platelet-rich plasma (PRP) in improving endometrial function in cases with repeated implantation failure and thin endometrium. However, the mechanism of this effect is unclear.

To investigate the direct effect of PRP on the implantation process during embryo transfer (ET) in cases without an obvious history of abnormality on implantation.

In this randomized clinical trial study, 55 infertile women (20–40 yr) who were candidates for intracytoplasmic sperm injection referred to the Infertility Center of Fatemiyeh hospital in Hamadan, Iran between September 2022 and 2023were randomly divided into intervention and control groups. In the intervention group, PRP was added to the ET medium, while in the control group, a routine ET medium was used. After ET, chemical and clinical pregnancy were measured.

In the intervention and control groups beta human chorionic gonadotropin positivity 14 days after transfer was 33.3% and 39.3%, consecutively (p = 0.646). On day 21 post-transfer, a gestational sac was observed in 33.3% and 35.7% of cases (p = 0.646). By 28 days after transfer fetal heart activity was detected in 33.3% and 35.7% of cases (p = 0.631).

The addition of autologous PRP at the time of ET does not have a direct positive effect on embryo implantation, and the observation of positive effects in previous studies may be indirectly on the uterine microenvironment, which requires time.

## Full-text entities

- **Genes:** CXCL13 (C-X-C motif chemokine ligand 13) [NCBI Gene 10563] {aka ANGIE, ANGIE2, BCA-1, BCA1, BLC, BLR1L}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, HOXA10 (homeobox A10) [NCBI Gene 3206] {aka HOX1, HOX1.8, HOX1H, PL}, MMP26 (matrix metallopeptidase 26) [NCBI Gene 56547], MFSD11 (major facilitator superfamily domain containing 11) [NCBI Gene 79157] {aka ET}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743] {aka COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2}, MMP7 (matrix metallopeptidase 7) [NCBI Gene 4316] {aka MMP-7, MPSL1, PUMP-1}, MMP3 (matrix metallopeptidase 3) [NCBI Gene 4314] {aka CHDS6, MMP-3, SL-1, STMY, STMY1, STR1}, MMP1 (matrix metallopeptidase 1) [NCBI Gene 4312] {aka CLG}, CCL5 (C-C motif chemokine ligand 5) [NCBI Gene 6352] {aka D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228}, CGB5 (chorionic gonadotropin subunit beta 5) [NCBI Gene 93659] {aka CGB, HCG}, CCL7 (C-C motif chemokine ligand 7) [NCBI Gene 6354] {aka FIC, MARC, MCP-3, MCP3, NC28, SCYA6}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, GNRH1 (gonadotropin releasing hormone 1) [NCBI Gene 2796] {aka GNRH, GRH, LHRH, LNRH}
- **Diseases:** diabetes (MESH:D003920), hypothyroidism (MESH:D007037), abortion (MESH:D000026), ET (MESH:D020964), endocrine disorders (MESH:D004700), male-factor infertility (MESH:D007248), fibrosis (MESH:D005355), intrauterine adhesions (MESH:D000267), inflammatory (MESH:D007249), RIF (MESH:D051437), Spontaneous abortion (MESH:D000022), Infertility (MESH:D007246), hyperprolactinemia (MESH:D006966), hyperthyroidism (MESH:D006980)
- **Chemicals:** ET medium (-), lipoxin A4 (MESH:C040527), estradiol (MESH:D004958)
- **Species:** Homo sapiens (human, species) [taxon 9606], Bos taurus (bovine, species) [taxon 9913]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12268272/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12268272/full.md

## References

31 references — full list in the complete paper: https://tomesphere.com/paper/PMC12268272/full.md

---
Source: https://tomesphere.com/paper/PMC12268272